InMed and the laboratory of Dr. Vikramaditya Yadav at the University of British Columbia collaborate on a proprietary biosynthesis technology to produce bioidentical, high purity, high grade cannabinoids. The host selected is E.coli. In this video, Dr. Yadav talks how an E.coli-based system is uniquely suited for producing cannabinoids.
![](https://www.inmedpharma.com/wp-content/uploads/2024/07/INM-InMed-at-Benzinga-Health-and-Biotech-Breakthroughs-June-2024.png)
InMed Presents at Benzinga’s Healthcare and Biotech Breakthroughs
InMed’s CEO Eric A. Adams featured at Benzinga’s Healthcare and Biotech Breakthroughs Event. Host Zunaid Suleman spoke with Eric Adams about InMed’s drug candidate INM-901